BioVascular Overview

  • Founded
  • 2005

Founded
  • Status
  • Private

  • Employees
  • 4

Employees
  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 1

BioVascular General Information

Description

Developer of drugs and devices designed to commercialize novel cardiovascular therapeutics for significant unmet medical needs. The company's devices control intimal hyperplasia associated with vascular procedures and control factors associated with cardiovascular morbidity and mortality, develop drugs for either hemodialysis access grafts or peripheral bypass grafting, helping medical clinics for the treatment and prevention of vascular diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Therapeutic Devices
Primary Office
  • 12230 El Camino Real
  • Suite 100
  • San Diego, CA 92130
  • United States
+1 (858) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioVascular Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private 0000 Completed Generating Revenue
4. Secondary Transaction - Private 01-Mar-2017 0000 Completed Generating Revenue
3. Later Stage VC (Series C) 07-Feb-2008 000.00 0000 000.00 Completed Generating Revenue
2. Early Stage VC (Series B) 01-Nov-2007 $4.09M $8.09M 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) 11-Jul-2005 $4M $4M 0000 Completed Startup
To view BioVascular’s complete valuation and funding history, request access »

BioVascular Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.00
Series B 0,000,000 00.000000 00 00 00 00 00 00.000
Series A 4,000,000 $0.001000 8% $1 $1 1x $1 14.6%
To view BioVascular’s complete cap table history, request access »

BioVascular Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of drugs and devices designed to commercialize novel cardiovascular therapeutics for significant unmet medical
Biotechnology
San Diego, CA
4 As of 2020
0000
000000 - 000 0000

000000

ore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip
0000 000000000
Cambridge, MA
000 As of 0000
00000
00000000 00000

000000

t, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. U
0000000000000
Palma, Spain
00 As of 0000
00000
0000 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BioVascular Competitors (39)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sarepta Therapeutics Formerly VC-backed Cambridge, MA 000 00000 00000000 00000
0000000 Venture Capital-Backed Palma, Spain 00 00000 000000&0 00000
000000000 00000000 Venture Capital-Backed Hennigsdorf, Germany 00 000.00 0000000000 0 000.00
000000 000 Venture Capital-Backed San Francisco, CA 00 00000 00000000000 00000
0000000 000 Venture Capital-Backed San Diego, CA 00 000.00 00000000000 000.00
You’re viewing 5 of 39 competitors. Get the full list »

BioVascular Patents

BioVascular Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-0918740-D0 Controlled release compositions of agents that reduce circulating levels of platelets and methods thereof Granted 16-Jun-2008 0000000000
GB-0905567-D0 Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor Granted 16-Jun-2008 0000000000
CA-2728213-A1 Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor Abandoned 16-Jun-2008 0000000000
GB-2460915-B Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor Expired - Fee Related 16-Jun-2008 0000000000 0
GB-2462022-A Controlled release compositions for use in reducing circulating levels of platelets Granted 16-Jun-2008 A61K9/1676 0
To view BioVascular’s complete patent history, request access »

BioVascular Executive Team (4)

Name Title Board Seat Contact Info
John Parrish Ph.D Co-Founder, President, Chief Executive Officer & Board Member
Paul Glidden Ph.D Co-Founder & Board Member
Alison Pilgrim Ph.D Chief Medical Officer & Vice President, Clinical Research & Regulatory Affairs
Christopher Bussineau Ph.D Vice President of Pharmaceutical Operations
To view BioVascular’s complete executive team members history, request access »

BioVascular Board Members (6)

Name Representing Role Since
Arno Hartmann Ph.D Self Board Member 000 0000
Brian Dovey Domain Associates Board Member 000 0000
John Parrish Ph.D BioVascular Co-Founder, President, Chief Executive Officer & Board Member 000 0000
Martin Munchbach Ph.D Self Board Member 000 0000
Paul Glidden Ph.D BioVascular Co-Founder & Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

BioVascular Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioVascular Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BB Biotech Asset Manager Minority 000 0000 000000 0
To view BioVascular’s complete investors history, request access »

BioVascular Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 10-Sep-2007 0000000000 Drug Discovery 0000 0000
To view BioVascular’s complete acquisitions history, request access »